[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 517 Engrossed in House (EH)]

<DOC>
H. Res. 517

                In the House of Representatives, U. S.,

                                                      December 3, 2019.
Whereas the Global Fund to fight AIDS, tuberculosis (TB), and malaria is an 
        effective partnership of governments, the private sector, civil society, 
        and affected communities to transform the response to these epidemics;
Whereas since the Global Fund's creation in 2002, and in close cooperation with 
        the President's Emergency Plan for AIDS Relief (PEPFAR), more than 
        32,000,000 lives have been saved in countries where the Global Fund 
        invests;
Whereas the Global Fund has contributed to extraordinary improvements in global 
        health, including by helping to reduce by half the number of AIDS-
        related deaths since 2005, contributing to a 37-percent decline in TB 
        deaths from 2000 to 2016, and a 60-percent decline in the number of 
        malaria deaths since 2000;
Whereas the Global Fund and its partners work to uphold a steadfast commitment 
        to transparency and accountability, receiving high marks in multilateral 
        aid reviews and by independent watchdogs;
Whereas despite progress achieved to date in combating AIDS, TB, and malaria, 
        significant challenges threaten future progress, including drug and 
        insecticide resistance, reaching marginalized and vulnerable 
        populations, and complacency in the fight against infectious diseases;
Whereas United States leadership has been critical to the Global Fund's success 
        as its largest donor and through its oversight role on the Board of the 
        Global Fund;
Whereas the Global Fund amplifies and supports the results of United States 
        bilateral heath programs, including the PEPFAR, the President's Malaria 
        Initiative, and the United States Agency for International Development 
        TB program;
Whereas a statutory cap on United States contributions to the Global Fund has 
        successfully leveraged increased contributions from other donors in 
        prior Global Fund replenishments;
Whereas the United Kingdom and Japan, for example, already have pledged 
        significant increases to the Global Fund for the Sixth Replenishment;
Whereas the Global Fund's requirements for cofinancing have spurred domestic 
        investments, with recipient countries committing 41 percent more of 
        their own funding to fight AIDS, TB, and malaria for 2018 to 2020 
        compared to 2015 to 2017;
Whereas recipient countries are expected to increase their co-financing by 48 
        percent, growing to $46,000,000,000 from 2021 to 2023; and
Whereas with these resources secured, the Global Fund projects it will reduce 
        the number of deaths due to AIDS, TB, and malaria by nearly 50 percent, 
        avert 234,000,000 infections or disease cases, and save an additional 
        16,000,000 lives: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) encourages the Global Fund and its partners to continue their 
        valuable contributions to end the epidemics of AIDS, TB, and malaria;
            (2) affirms previous commitments of the United States to providing 
        33 percent of the budget to the Global Fund, including for the Sixth 
        Global Fund Replenishment held on October 10, 2019, in Lyon, France, as 
        demonstrated by the $1,560,000,000 provided by H.R. 2839 in the 116th 
        Congress (providing FY2020 appropriations for the Department of State, 
        foreign operations, and related programs), as passed by the House of 
        Representatives;
            (3) urges donor countries to step up the fight and increase their 
        pledges for the Sixth Global Fund Replenishment and supports continued 
        diplomatic engagement to improve burden sharing;
            (4) urges Global Fund recipient countries to continue to make and 
        meet ambitious cofinancing commitments to sustain progress in ending the 
        epidemics of AIDS, TB, and malaria; and
            (5) encourages United States bilateral aid programs to continue 
        their collaboration with the Global Fund to maximize the life-saving 
        impact of global health investments.
            Attest:

                                                                          Clerk.